FDA Inspection 1170764 — Versiti Blood Health Inc
The FDA completed an inspection of Versiti Blood Health Inc on May 25, 2022 in Yorkville, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 25, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Yorkville, IL (United States)